External Evaluation of Two Fluconazole Infant Population Pharmacokinetic Models

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01352-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Fuzzy Evaluation of Pharmacokinetic Models

Computational Intelligence and Neuroscience
MedicineMathematicsComputer ScienceNeuroscience
2018English

Pharmacokinetic Evaluation of Two Dosage Regimens of Clindamycin Phosphate.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1989English

Clinical Evaluation of Population Pharmacokinetic Parameters in Phenytoin Dosage Adjustment.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1989English

Population Pharmacokinetics of Fluconazole in Young Infants

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Integrated Two‐Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non‐Hodgkin Lymphoma

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2019English

A Two-Compartment Population Pharmacokinetic–Pharmacodynamic Model of Digoxin in Adults, With Implications for Dosage

Therapeutic Drug Monitoring
Pharmacology
2014English

A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim

AAPS Journal
Pharmaceutical Science
2018English

Performance of an Iterative Two-Stage Bayesian Technique for Population Pharmacokinetic Analysis of Rich Data Sets

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy